110 related articles for article (PubMed ID: 7318879)
1. Proof of the linearity of the pharmacokinetics of alinidine in man.
Arndts D; Warnkross H; Rominger KL; Justus H
Eur J Clin Pharmacol; 1981; 21(3):201-7. PubMed ID: 7318879
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and metabolism of 14C-labelled alinidine in man and dogs.
Arndts D; Leb G; Förster HJ
Eur J Drug Metab Pharmacokinet; 1981; 6(3):225-36. PubMed ID: 7308242
[TBL] [Abstract][Full Text] [Related]
3. Alinidine pharmacokinetics following acute and chronic dosing.
Harron DW; Arndts D; Shanks RG
Br J Clin Pharmacol; 1982 Jun; 13(6):821-7. PubMed ID: 7093113
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic properties of alinidine in man.
Wiegand UW; Kasper W; Meinertz T; Stützle U; Jähnchen E
J Cardiovasc Pharmacol; 1982; 4(1):59-62. PubMed ID: 6176801
[TBL] [Abstract][Full Text] [Related]
5. Blood level, distribution, metabolite pattern and excretion of [14C]alinidine in mice and rats.
Bechtel WD; Richter I
Eur J Drug Metab Pharmacokinet; 1986; 11(3):175-86. PubMed ID: 3816873
[TBL] [Abstract][Full Text] [Related]
6. An assessment of the contribution of clonidine metabolised from alinidine to the cardiovascular effects of alinidine.
Harron DW; Arndts D; Finch M; Shanks RG
Br J Clin Pharmacol; 1983 Oct; 16(4):451-5. PubMed ID: 6626441
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of adimolol after single and multiple dose administration in healthy volunteers.
Wiedemann I; Peil H; Justus H; Adamus S; Brantl V; Lohmann H
Arzneimittelforschung; 1985; 35(6):964-9. PubMed ID: 2862877
[TBL] [Abstract][Full Text] [Related]
8. Development and quality control of a highly sensitive radioimmunoassay for alinidine.
Arndts D; Stähle H
J Pharmacol Methods; 1981 Sep; 6(2):109-20. PubMed ID: 7289628
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of orally administered tizanidine in healthy volunteers.
Tse FL; Jaffe JM; Bhuta S
Fundam Clin Pharmacol; 1987; 1(6):479-88. PubMed ID: 3447935
[TBL] [Abstract][Full Text] [Related]
11. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.
Setnikar I; Rovati LC
Arzneimittelforschung; 2001 Sep; 51(9):699-725. PubMed ID: 11642003
[TBL] [Abstract][Full Text] [Related]
12. Cardiac electrophysiologic effects of alinidine, a specific bradycardic agent, in the conscious dog: plasma concentration-response relations.
Boucher M; Chassaing C; Chapuy E
J Cardiovasc Pharmacol; 1995 Feb; 25(2):229-33. PubMed ID: 7752648
[TBL] [Abstract][Full Text] [Related]
13. Binding of two specific bradycardic agents, alinidine and AQ-A 39, to muscarinic receptors of guinea pig atria and ventricle.
Brunner F; Kukovetz WR
J Cardiovasc Pharmacol; 1988 Feb; 11(2):222-9. PubMed ID: 2452318
[TBL] [Abstract][Full Text] [Related]
14. Clonidine kinetics in man--evidence for dose dependency and changed pharmacokinetics during chronic therapy.
Frisk-Holmberg M; Paalzow L; Edlund PO
Br J Clin Pharmacol; 1981 Nov; 12(5):653-8. PubMed ID: 7332729
[TBL] [Abstract][Full Text] [Related]
15. New aspects in the metabolism of alinidine in man.
Arndts D; Forster HJ
Eur J Drug Metab Pharmacokinet; 1981; 6(4):313-5. PubMed ID: 7333332
[No Abstract] [Full Text] [Related]
16. New aspects of the pharmacokinetics and pharmacodynamics of clonidine in man.
Arndts D; Doevendans J; Kirsten R; Heintz B
Eur J Clin Pharmacol; 1983; 24(1):21-30. PubMed ID: 6832197
[TBL] [Abstract][Full Text] [Related]
17. Zatebradine: pharmacokinetics of a novel heart-rate-lowering agent after intravenous infusion and oral administration to healthy subjects.
Roth W; Bauer E; Heinzel G; Cornelissen PJ; van Tol RG; Jonkman JH; Zuiderwijk PB
J Pharm Sci; 1993 Jan; 82(1):99-106. PubMed ID: 8429501
[TBL] [Abstract][Full Text] [Related]
18. Dose linearity of lacidipine pharmacokinetics after single and repeated oral doses in healthy volunteers.
Da Ros L; Squassante L; Milleri S
Clin Pharmacokinet; 2003; 42(1):99-106. PubMed ID: 12489980
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and concentration-effect relationships of intervenous and oral clonidine.
Davies DS; Wing AM; Reid JL; Neill DM; Tippett P; Dollery CT
Clin Pharmacol Ther; 1977 May; 21(5):593-601. PubMed ID: 870272
[TBL] [Abstract][Full Text] [Related]
20. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
